Re‑Articulating the Strategic Value of HEOR Beyond ‘Supporting’ Clinical Evidence
1:30 pm - Thursday 29th October 2026
- Re-articulating the strategic value of HEOR beyond ‘supporting’ clinical evidence
- Demonstrating ROI when studies take 12–24 months but decisions demand speed
- Building stronger advocacy and communication skills within HEOR leadership
Speakers:
Executive Director, Health Economics & Outcomes Research, Cardio-Renal-Metabolic
Boehringer Ingelheim